289 related articles for article (PubMed ID: 26425251)
1. Dabigatran-Associated Intracranial Hemorrhage: Literature Review and Institutional Experience.
King AE; Szarlej DK; Rincon F
Neurohospitalist; 2015 Oct; 5(4):234-44. PubMed ID: 26425251
[TBL] [Abstract][Full Text] [Related]
2. Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.
van Ryn J; Stangier J; Haertter S; Liesenfeld KH; Wienen W; Feuring M; Clemens A
Thromb Haemost; 2010 Jun; 103(6):1116-27. PubMed ID: 20352166
[TBL] [Abstract][Full Text] [Related]
3. Reversing the anticoagulation effects of dabigatran.
Dager WE; Banares L
Hosp Pract (1995); 2017 Apr; 45(2):29-38. PubMed ID: 28335637
[TBL] [Abstract][Full Text] [Related]
4. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
Brunetti L; Chen C; White J
Consult Pharm; 2014 Mar; 29(3):169-78. PubMed ID: 24589766
[TBL] [Abstract][Full Text] [Related]
5. Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease.
Bovio JA; Smith SM; Gums JG
Ann Pharmacother; 2011 May; 45(5):603-14. PubMed ID: 21540406
[TBL] [Abstract][Full Text] [Related]
6. Dabigatran etexilate: A novel oral direct thrombin inhibitor.
Blommel ML; Blommel AL
Am J Health Syst Pharm; 2011 Aug; 68(16):1506-19. PubMed ID: 21817082
[TBL] [Abstract][Full Text] [Related]
7. Removal of dabigatran by hemodialysis.
Chang DN; Dager WE; Chin AI
Am J Kidney Dis; 2013 Mar; 61(3):487-9. PubMed ID: 23219111
[TBL] [Abstract][Full Text] [Related]
8. Dabigatran for the prevention and treatment of thromboembolic disorders.
Enriquez A; Baranchuk A; Redfearn D; Simpson C; Abdollah H; Michael K
Expert Rev Cardiovasc Ther; 2015 May; 13(5):529-40. PubMed ID: 25843430
[TBL] [Abstract][Full Text] [Related]
9. Neurosurgical complications of direct thrombin inhibitors--catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran.
Garber ST; Sivakumar W; Schmidt RH
J Neurosurg; 2012 May; 116(5):1093-6. PubMed ID: 22394293
[TBL] [Abstract][Full Text] [Related]
10. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
Le Roux P; Pollack CV; Milan M; Schaefer A
J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
[TBL] [Abstract][Full Text] [Related]
11. A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage: A Single-Center University Hospital Experience.
Kumar R; Smith RE; Henry BL
J Intensive Care Med; 2015 Dec; 30(8):462-72. PubMed ID: 24668159
[TBL] [Abstract][Full Text] [Related]
12. The acute management of haemorrhage, surgery and overdose in patients receiving dabigatran.
Alikhan R; Rayment R; Keeling D; Baglin T; Benson G; Green L; Marshall S; Patel R; Pavord S; Rose P; Tait C
Emerg Med J; 2014 Feb; 31(2):163-8. PubMed ID: 23435652
[TBL] [Abstract][Full Text] [Related]
13. Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.
Baetz BE; Spinler SA
Pharmacotherapy; 2008 Nov; 28(11):1354-73. PubMed ID: 18956996
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series.
Ross B; Miller MA; Ditch K; Tran M
J Med Toxicol; 2014 Jun; 10(2):223-8. PubMed ID: 24385325
[TBL] [Abstract][Full Text] [Related]
15. Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report.
Faust AC; Peterson EJ
J Emerg Med; 2014 Apr; 46(4):525-9. PubMed ID: 24508114
[TBL] [Abstract][Full Text] [Related]
16. Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation.
Scott KA; Amirehsani KA
J Am Assoc Nurse Pract; 2015 Apr; 27(4):190-6. PubMed ID: 25066647
[TBL] [Abstract][Full Text] [Related]
17. New options with dabigatran etexilate in anticoagulant therapy.
Maegdefessel L; Spin JM; Azuma J; Tsao PS
Vasc Health Risk Manag; 2010 May; 6():339-49. PubMed ID: 20531953
[TBL] [Abstract][Full Text] [Related]
18. Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment.
Watanabe M; Siddiqui FM; Qureshi AI
Neurocrit Care; 2012 Feb; 16(1):203-9. PubMed ID: 21748501
[TBL] [Abstract][Full Text] [Related]
19. Dabigatran Etexilate: A Review in Nonvalvular Atrial Fibrillation.
Blair HA; Keating GM
Drugs; 2017 Mar; 77(3):331-344. PubMed ID: 28185082
[TBL] [Abstract][Full Text] [Related]
20. What neurosurgeons need to know about dabigatran etexilate (pradax(®)/pradaxa(®)/prazaxa(®)).
Dwyer CM; Damodaran O; Heckelmann M; Sheridan MM
Asian J Neurosurg; 2015; 10(2):66-8. PubMed ID: 25972932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
